department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Crexont · pharmadog

pharmadog
drugs
Crexont

drug

patient view →

Crexont

Marketedupdated 2mo ago

by $AMRX Amneal Pharmaceuticals, Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Crexont

generic

(carbidopa + levodopa)

indication

Parkinson's Disease

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval4 co-mentions · 2 sources
drugSINEMET CR3 co-mentions · 3 sources
tagSmall Molecule2 co-mentions · 2 sources
druglevodopa CR1 co-mentions · 1 sources
drugWD-18041 co-mentions · 1 sources
drug(carbidopa + levodopa)1 co-mentions · 1 sources
drugRytary1 co-mentions · 1 sources
drugINBRIJA1 co-mentions · 1 sources

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Trials studying Crexont

phase4BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Diseaserecruitingn=22
phase4A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Diseaserecruitingn=220